Vertex On Track To Significantly Improve Revenue And Earnings By 2030
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX ) reported decent Q1 earnings yesterday, despite falling short of analyst estimates for both revenue and earnings. Statistically, positive earnings surprises have shown strong predictive power of stock price movements in the short term, but asDilantha De Silva is an experienced equity analyst and investment researcher with over 10 years in the investment industry. He writes insightful articles for Seeking Alpha, GuruFocus, TipRanks, and ValueWalk, with a sig ...